{"database":"GEO","file_versions":[],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Homo sapiens"],"gds_type":["Expression profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE333537"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"Phase I trial of intravenous VCN-01 oncolytic adenovirus and durvalumab in patients with head and neck metastatic squamous cell carcinoma refractory to immunotherapy","description":"VCN-01 is a hyaluronidase-expressing oncolytic adenovirus that increases immune checkpoint antibody tumor uptake in mice. VCN-01 was evaluated with durvalumab in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) patients refractory to anti-PD-(L)1","dates":{"publication":"2026/06/03"},"accession":"GSE333537","cross_references":{"GSM":["GSM9768156","GSM9768134","GSM9768155","GSM9768133","GSM9768136","GSM9768135","GSM9768138","GSM9768137","GSM9768139","GSM9768150","GSM9768152","GSM9768130","GSM9768151","GSM9768132","GSM9768154","GSM9768153","GSM9768131","GSM9768123","GSM9768145","GSM9768144","GSM9768122","GSM9768147","GSM9768125","GSM9768146","GSM9768124","GSM9768149","GSM9768127","GSM9768126","GSM9768148","GSM9768129","GSM9768128","GSM9768141","GSM9768140","GSM9768143","GSM9768142"],"GPL":["18573"],"GSE":["333537"],"taxon":["Homo sapiens"]}}